arrow
R

Ruanne V. Barnabas

institute for health metrics & evaluation
H指数:53
被引数:9,743

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and durability of immediate versus delayed single-dose HPV vaccination for persistent infection among young women in Kenya: a randomized, blinded, cross-over clinical trial

肯尼亚年轻女性中即时与延迟单剂量HPV疫苗接种对持续性感染的疗效与持久性:一项随机、盲法、交叉临床试验

2026-05-110
OAAI
Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study

全球范围内宫颈癌健康不公平现象显著加剧:一项全球模拟研究(在缺乏加强人乳头瘤病毒疫苗接种和筛查努力的情况下)

2026-04-300
PRE
Integrating clinical decision support and mobile health for differentiated HIV service delivery in Lesotho (VITAL): a cluster-randomised non-inferiority trial

整合临床决策支持与移动健康,以差异化提供莱索托艾滋病服务(VITAL):一项集群随机非劣效性试验

2026-04-020
OAAI
Cross-sectional study evaluating organizational climate, change commitment, and change efficacy for predicting family planning clinics' success in increasing HIV counseling and testing in Mombasa, Kenya

横断面研究评估组织气候、变革承诺和变革效能对预测肯尼亚蒙巴萨地区计划生育诊所增加艾滋病咨询与检测服务成功性的作用。

2025-12-310
PRE
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets

谁在性健康和生殖健康方面支付费用,什么措施能带来回报?对干预措施的成本和成本效益的回顾,以及对未来资金和市场的启示

2025-10-300
PRE
Brief Report:Maternal HIV Retesting During Pregnancy and Postpartum Among High-Risk Populations in Kenya, South Africa, and Ukraine: Cost-Effectiveness of Preventing Vertical Transmission

简报:肯尼亚、南非和乌克兰高风险人群中孕期及产后艾滋病病毒(HIV)复检:预防垂直传播的成本效益

2025-08-180
OA
Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results
2023-12-0412
OAAI